These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2809689)

  • 61. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
    Bowie WR; Lee CK; Alexander ER
    J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Electron microscopic studies of the action of erythromycin, doxycycline and ofloxacin on the growth cycle of Chlamydia trachomatis].
    Dailloux M; Kohler C; Laurain C; Le Faou A; Grignon G
    Pathol Biol (Paris); 1994 May; 42(5):399-405. PubMed ID: 7824303
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
    Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chlamydial infections and the quinolones.
    Ronald AR; Peeling RW
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):351-4. PubMed ID: 1864296
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
    Slaney L; Chubb H; Ronald A; Brunham R
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The action of quinolone carboxylic acids on Chlamydia trachomatis in vitro.
    Richmond SJ; Heppleston C; Bailey J
    Biochem Soc Trans; 1986 Apr; 14(2):503-4. PubMed ID: 2940134
    [No Abstract]   [Full Text] [Related]  

  • 69. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.
    Hammerschlag MR
    Rev Infect Dis; 1982; 4(2):500-5. PubMed ID: 6981168
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis.
    Demars R; Weinfurter J; Guex E; Lin J; Potucek Y
    J Bacteriol; 2007 Feb; 189(3):991-1003. PubMed ID: 17122345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activity of thiamphenicol against Chlamydia trachomatis and Neisseria gonorrhoeae.
    Ridgway GL; Felmingham D; Mumtaz G; O'Hare M
    Sex Transm Dis; 1984; 11(4 Suppl):432-4. PubMed ID: 6441286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An open label comparative study of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore.
    Tan HH; Chan RK
    Singapore Med J; 1999 Aug; 40(8):519-23. PubMed ID: 10572491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.
    Lefevre JC; Lepargneur JP; Guion D; Bei S
    Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical studies of Chlamydia trachomatis in male urethritis].
    Watanabe H; Hori T; Sasaki S; Noguchi Y; Washida H
    Hinyokika Kiyo; 1989 Jan; 35(1):77-81. PubMed ID: 2729024
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis.
    Yamano H; Yamazaki T; Sato K; Shiga S; Hagiwara T; Ouchi K; Kishimoto T
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2519-21. PubMed ID: 15917561
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis.
    Zanetti S; Usai D; Nonis A; Fadda G
    J Antimicrob Chemother; 1996 Feb; 37(2):357-9. PubMed ID: 8707747
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis.
    Takahashi S; Ichihara K; Hashimoto J; Kurimura Y; Iwasawa A; Hayashi K; Sunaoshi K; Takeda K; Suzuki N; Satoh T; Tsukamoto T
    J Infect Chemother; 2011 Jun; 17(3):392-6. PubMed ID: 21174140
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Techniques for culturing and determining antimicrobial susceptibility of Chlamydia trachomatis.
    Rota TR
    Arch Androl; 1980 Feb; 4(1):63-9. PubMed ID: 7356376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis.
    Richmond SJ; Bhattacharyya MN; Maiti H; Chowdhury FH; Stirland RM; Tooth JA
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():149-53. PubMed ID: 3182458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.